News from sanofi A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NYSE:SNY)

Mar 25, 2015, 12:15 ET
Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age

Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration...

Mar 25, 2015, 08:00 ET

Skin Care Brand NeoStrata® Canada Joins Forces with Canadian activewear brand Lolë

NeoStrata to take part in the 2015 edition of the Lolë White Tour™ across Canada MONTREAL, March 25, 2015 /CNW Telbec/ - Canadian...

Mar 19, 2015, 07:00 ET

Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide)

 Sanofi announced today top-line results of the Phase IIIb ELIXA cardiovascular outcomes study, which compared lixisenatide to placebo in a...

Mar 15, 2015, 11:00 ET
Sanofi logo

Sanofi and Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced that 18-month (78-week) results of a Phase 3 trial of Praluent™ (alirocumab),...

Feb 25, 2015, 20:25 ET

Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo®

 Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300...

Feb 05, 2015, 07:49 ET
Sanofi Delivers Business EPS Growth of 7.3% at CER in 2014

Sanofi Delivers Business EPS Growth of 7.3% at CER in 2014

 Sanofi (NYSE: SNY; EURONEXT: SAN) Q4 2014 Change (reported) Change (CER) 2014 Change (reported) Change (CER) Net...

Feb 05, 2015, 02:16 ET

Sanofi - Résultats 2014 - Interview du Président du Conseil d'administration & DG Serge Weinberg

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour l'année 2014. Le Président du Conseil...

Feb 05, 2015, 02:14 ET

Sanofi FY 2014 - Interview With Chairman & CEO Serge Weinberg

Sanofi, a global and diversified healthcare leader, reports annual results for 2014. Chairman of the Board of Directors and CEO Serge Weinberg...

Feb 03, 2015, 07:00 ET
Afrezza(R) Inhaler with 8 unit and 4 unit cartridges of Afrezza (insulin human) Inhalation Powder.

Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.

 Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now...

Dec 12, 2014, 08:00 ET

Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...

Dec 02, 2014, 08:35 ET

Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection

 Sanofi announced today that following a priority review, the U.S. Food and Drug Administration has approved Priftin® (rifapentine) in...

Nov 19, 2014, 08:15 ET
Sanofi

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

 Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new detailed positive results from six Phase 3 ODYSSEY trials that...

Nov 18, 2014, 11:22 ET
Sanofi

Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator

As part of its contribution to the global response to the Ebola epidemic, Sanofi announced today that it has appointed Chief Scientific Officer Dr....

Nov 03, 2014, 08:30 ET
Sanofi Pasteur Logo

Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...

Oct 28, 2014, 08:34 ET
Infographic

Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER

Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2014 Change (reported) Change (CER) Net...

Oct 28, 2014, 03:13 ET

Sanofi - Résultats T3 2014 : Interview du Directeur Financier Jérôme Contamine

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le troisième trimestre 2014. Le Directeur...

Oct 28, 2014, 03:00 ET

Sanofi Q3 2014 Results - Interview with Jérôme Contamine

Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2014. Jérôme Contamine, Chief Financial...

Oct 15, 2014, 13:00 ET

Presenta Sanofi campaña para prevenir osteoartritis en rodillas

La osteoartritis (OA) es una de las primeras 10 causas de invalidez total en México, lo que incrementa la carga económica y social del...

Oct 15, 2014, 08:00 ET

New Survey Finds Differences In Attitudes About Diabetes Based On Age

 Sanofi US announced today the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes...

Sep 17, 2014, 08:34 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic...